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Abstract
Background: The clock molecule plays major roles in circadian rhythmicity and regulating lipid and glucose
metabolism in peripheral organs. Disruption of the circadian rhythm can lead to cardiometabolic disorders. The
existence of small dense low-density lipoprotein (sdLDL) in the circulation, an abnormality of lipid metabolism, in
part associated with lifestyle, is also one of risk parameters for cardiometabolic disorders. The 3111 T/C single
nucleotide polymorphism (SNP) of the Clock gene has been reported to be associated with lifestyle including
morning/evening preference. We investigated whether the Clock 3111 T/C SNP may affect lipids and lipoproteins
including sdLDL.
Methods: In 365 community-dwelling subjects (170 men and 195 women, mean age 63 ± 14 years), the 3111 T/C
SNP was genotyped using a fluorescent allele-specific DNA primer assay system. The levels of sdLDL were
measured with the electrophoretic separation of lipoproteins employing the Lipoprint system.
Results: The frequency of the Clock 3111 C allele was 0.14. The area of sdLDL did not differ between the subjects
with obesity and those without. In carriers of T/T homozygotes, the area of sdLDL was significantly higher
compared with carriers of the C allele (T/C or C/C) (1.7 ± 3.4 vs. 0.8 ± 1.9%; p < 0.05). A multiple regression analysis
showed that the area of sdLDL was significantly and negatively correlated with the Clock 3111 T/C SNP (b = -0.114,
p < 0.05), independently of age, sex, body mass index, and exercise habits.
Conclusion: Our findings indicated that the Clock 3111 T/C SNP might be associated with the existence of sdLDL.
Background
Sleep can be interrelated with various lifestyle and
genetic factors. The sleep-wake cycle is generated
through circadian rhythmicity and homeostasis [1,2]. In
mammals, physiological processes show approximate 24-
hour rhythms [3] derived by the clock molecules con-
trolled not only by the master circadian clock in the
suprachiasmatic nucleus (SCN) [4-6] but also by periph-
eral clocks in the liver, muscle, and adipose tissue [7-9].
The clock molecule groups, such as brain and muscle
Arnt-like protein-1 (BMAL1) and circadian locomotor
output cycles protein kaput (CLOCK), also play major
roles in circadian rhythmicity and regulating lipid and
glucose metabolism in peripheral organs [10]. The
human Clock gene located on chromosome 4q12 has a
basic helix-loop-helix domains (for binding DNA).
Mutant mice homozygous for Clock exibit an altered
diurnal feeding rhythm, developing metabolic syndrome
with hyperlipidemia [11], and a reduced amount of time
spent asleep both in entrained and free-running condi-
tions [12]. So, disruption of the circadian rhythm leads
to metabolic and sleep disorders. A single nucleotide
polymorphism (SNP), 3111 T/C, located in the 3’-flank-
ing region of the Clock gene was reported to be a pre-
dictor of diurnal preference in humans [13], although
another study reported that the Clock 3111 C allele is
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not associated with eveningness [14]. The 3111 T/C
SNP influenced sleep and the activity patterns in people
affected by bipolar depression, through a possible effect
on the stability of mRNA of the Clock gene and the
level of Clock protein [15].
Small dense low-density lipoprotein (sdLDL) is pro-
duced by abnormal lipid metabolism which leads to
increased triglycerides (TG) levels and a difference in
clearance between normal and abnormal TG-rich lipo-
proteins [16]. The existence of sdLDL in the circulation
is associated with diabetes mellitus [17,18], diabetic
nephropathy [19-21], metabolic syndrome [22], and cor-
onary artery disease (CAD) [23,24]. SdLDL emerges, in
part, through lifestyle and genetic factors [25-28]. In this
study, we investigate whether the 3111 T/C SNP of the




All participants were recruited through an annual health
check up in the Mima city, Tokushima prefecture in
Japan. A total of 365 Japanese community-dwelling sub-
jects, 170 men and 195 women; aged 24 to 88 years,
were enrolled in this study. We included subjects who
were asymptomatic without any known medical history
of coronary heart disease and psychic disease. The study
protocol was approved by the Ethics committee of
National Hospital Organization Kyoto Medical Center.
All the subjects signed an informed consent form after
being fully informed about all aspects of the study
before enrolling. After an overnight fast, body weight
and height were measured using a body fat analyzer
(OMRON. Co. Ltd., Osaka, Japan). The body mass
index (BMI) was calculated as weight divided by squared
height (kg/m2). The blood pressure was measured three-
times at 10-minute intervals using a mercury sphygmo-
manometer. Venous blood samples were then drawn for
blood tests. Blood glucose was measured by the hexoki-
nase method (SHINO-TEST Corporation, Tokyo,
Japan), and serum insulin was assayed by chemilumines-
cent immunoassay (Bayermedical.Co., Ltd., Tokyo,
Japan). Serum total cholesterol (Wako Pure Chemical
Industries, Ltd., Tokyo, Japan), high density lipoprotein
(HDL)-cholesterol, and triglyceride (DAIICHI PURE
CHEMICALS Co., Ltd., Tokyo, Japan) were determined
by the enzymatic methods. Homeostasis model assess-
ment of insulin resistance (HOMA-IR) was calculated
according to a previous study [29]. Medical histories
and lifestyle factors (exercise habits [none or done],
sleeping time, skipping breakfast and smoking habits)
were confirmed by a self-reported questionnaire and
medical professionals’ interview.
Measurement of the area of sdLDL
The area of sdLDL was measured with the Lipoprint™
system (Quantimetrix Inc., Redondo Beach, CA) [30].
Briefly, 25 μL of serum sample and 200 μL of loading
gel were applied to a 3.3% polyacrylamide gel tube and
mixed well several times. Next, these samples were
photopolymerized at room temperature for 30 min and
then electrophoresed for 65 min (3 mA/gel tube). After
the electrophoresis, a densitometric scanning was done
with a ScanMaker i900 (MICROTEK Co., Carson, CA)
and the lipoprotein subfractions were calculated with an
iMac personal computer (Apple Computer Inc., Cuper-
tino, CA). All the LDL subfractions were calculated
based on a relative flotation rate (Rf) between the very
LDL fraction as Rf = 0.0 and the HDL fraction as Rf =
1.0. LDL-1 and LDL-2 are defined as large LDL, and
LDL-3 to LDL-7 are defined as sdLDL. The area of
sdLDL is expressed as a percentage relative to total
lipoproteins.
Genetic analysis
A noninvasive method was implemented for collecting
buccal mucosa cells using cytobrushes. After the phe-
nol-extraction procedure, 0.2 to 2 μg of DNA was
obtained. Genotypes were determined with an intercala-
ter-mediated fluorescent allele-specific DNA primary
assay (TOYOBO Co. Ltd., Tsuruga, Japan). The 3111C/
T polymorphic region of Clock (rs1801260) was ampli-
fied using the polymerase chain reaction with sense (5’-
AAT ACC AGC CAG CAG GAG GTG ATC-3’) and
anti-sense (5’-CAA AAA ATA TCC AGG CAC CTA
AAA CAC TG-3’) primers, and labeled at the 5’ end
with Texas red (5’-ATA GGG GCA CAG CCA GTT C-
3’). PCR amplifications were performed under the condi-
tions recommended by the enzyme supplier. In brief, a
25-μL aliquot containing 20 ng of genomic DNA, the
reaction buffer supplied, 3.0 mM MgCl2, 0.2 mM
dNTP, and 1.25 U of rTaq containing anti-Taq high
(TOYOBO Co. Ltd., Tsuruga, Japan). Cycling para-
meters were an initial denaturation at 95°C for 5 min-
utes, then denaturation at 95°C for 30 secconds,
annealing at 65°C for 30 seconds, and primer extension
at 72°C for 30 seconds for 40 cycles, and post extension
at 72°C for 2 minutes in a thermal cycler (ABI9700).
Two microliters of reaction mixture containing 10
pmoL of probe and SYBR Green (final concentration ×
10000) was added to the PCR products. The mixture
was placed in the ABI PRIZM 7700 and the melting
temperature was measured. The program for analytical
melting was 95°C for 30 seconds, then 40°C for 1 min-
ute, increasing to 80°C by 10 minutes. The fluorescence
signals were detected at excitation and emission wave-
lengths of 485 nm and 612 nm. In this study, all
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samples have checked by two independent investigators.
No samples are observed different results.
Statistical analysis
All statistical analyses were performed with the Statisti-
cal Package of Social Science (SPSS for Windows, ver-
sion 11.0; SPSS Inc., Chicago, IL, USA). Data were
expressed as means ± SD. The present study was
designed to detect a difference in means equivalent to
1% of sdLDL with a SD of 3%. Thus, the sample size
required was 286 with an error of 5%, with 80% power
(beta = 20%) at the two-tailed 5% significance level. The
differences in values between groups were estimated by
using the Student’s unpaired t-test and c2-test. A step-
wise multiple regression analysis controlled for mea-
sured parameters including the Clock 3111 T/C SNP
was performed to explore the correlated factors with the
area of sdLDL. P < 0.05 was accepted as statistically
significant.
Results
Table 1 shows the distribution of the 3111 T/C SNP.
The sex difference in the frequency was not observed
(data not shown). The frequency of the C allele was
0.14, with 277 (75.9%) of subjects T/T homozygotes, 77
(21.1%) T/C heterozygotes, and 11 (3.0%) C/C homozy-
gotes. No significant deviation from Hardy-Weinberg
equilibrium was observed.
The physical characteristics and blood test results of the
subjects are listed in Table 2. There were no significant
differences between carriers of the C allele (T/C or C/C)
and T/T homozygotes in gender distribution, age, BMI,
systolic blood pressure, diastolic blood pressure, fasting
plasma glucose, fasting serum insulin, HOMA-IR, TG, or
total cholesterol and HDL-cholesterol levels. Moreover,
Table 1 Clinical and biological characteristics of subjects according to SNP of the Clock gene
Parameters T/T T/C C/C T/T + T/C T/C + C/C P value
Number 277 77 11 354 88
Age (years) 64 ± 14 65 ± 13 61 ± 17 64 ± 14 65 ± 14 0.559
Sex (men/women) 132/145 31/46 7/4 163/191 38/50 0.464
Skipping breakfast (%) 5 9 0 6 8 0.390
Smoking (current, %) 14 25 27 26 16 0.249
Exercise habit (none/done, %) 72/18 70/30 54/46 71/29 68/32 0.061
Sleeping time (%)a
< 6 hours 21.2 19.5 27.3 20.9 20.4
6 hours 20.9 10.4 0 18.6 9.1
7 hours 25.3 31.1 27.3 26.6 30.7 0.090
8 hours 24.2 33.8 27.3 26.3 33.0
≥ 9 hours 8.4 5.2 18.1 7.7 6.8
Body mass index (kg/m2) 24.0 ± 3.0 23.6 ± 3.3 25.8 ± 4.4 23.9 ± 3.1 23.9 ± 3.5 0.061
Systolic blood pressure (mmHg) 137 ± 19 134 ± 20 134 ± 21 136 ± 19 134 ± 20 0.228
Diastolic blood pressure (mmHg) 76 ± 12 76 ± 11 73 ± 15 76 ± 12 76 ± 11 0.735
Fasting plasma glucose (mmol/L) 5.7 ± 1.7 5.5 ± 1.9 5.9 ± 1.7 5.7 ± 1.7 5.6 ± 1.9 0.578
Fasting serum insulin (pmol/L) 47 ± 51 40 ± 29 35 ± 16 46 ± 47 40 ± 27 0.193
HOMA-IR 2.1 ± 2.9 1.8 ± 2.6 1.5 ± 0.7 2.1 ± 2.9 1.8 ± 2.5 0.331
Triglycerides (mmol/L) 1.13 ± 0.58 1.10 ± 0.51 1.00 ± 0.25 1.12 ± 0.57 1.09 ± 0.49 0.580
Total cholesterol (mmol/L) 4.84 ± 0.93 4.78 ± 0.88 4.29 ± 0.83 4.84 ± 0.91 4.73 ± 0.88 0.335
HDL-cholesterol (mmol/L) 1.42 ± 0.41 1.40 ± 0.36 1.40 ± 0.39 1.42 ± 0.39 1.42 ± 0.36 0.875
Small dense LDL (%) 1.7 ± 3.4 0.9 ± 2.0 0.3 ± 0.7 1.6 ± 3.2 0.8 ± 1.9 0.020
Data are means ± SD.
HOMA-IR, homeostasis model assessment of insulin resistance; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
P values in a comparison between subjects with T/T genotype and those with T/C or C/C (by using Student’s unpaired t-test and c2-test).
In another model (T/T + T/C vs. C/C), there were no significant differences in various traits (by using Student’s unpaired t-test and c2-test).
a Four subjects with T/T genotype had no answer.
Table 2 A stepwise multiple regression analysis for small
dense low-density lipoprotein




Fasting plasma glucose (mg/
dL)
0.013 (from [0.003] to [0.024]) 0.015
Sex 0.774 (from [0.118] to [1.431]) 0.021
Clock 3111 T/C SNP a -0.838 (from [-1.598] to
[-0.077])
0.031
* CI indicates coefficient interval.
a Clock 3111 SNP was scored as follows: T/T type = 0, C/T or C/C type = 1.
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the area of sdLDL was significantly higher in the T/T
homozygotes (1.7 ± 3.4 vs. 0.8 ± 1.9%). There was no dif-
ference in the area of sdLDL between subjects with and
without obesity (as BMI of more than 25 kg/m2).
In the questionnaire on lifestyle, there was no signifi-
cant difference in sleeping time between carriers and
non-carriers of the C allele (Table 2). Moreover, a step-
wise multiple regression analysis for the area of sdLDL
revealed a significant, negative, and independent associa-
tion of the Clock 3111 T/C SNP (b = -0.114, p = 0.031)
(Table 3).
Discussion
The present study is the first to demonstrate an associa-
tion between the Clock 3111 T/C SNP and sdLDL in
the circulation among community-dwelling people. The
most important finding is that the Clock 3111 T/T
homozygous form might increase the area of sdLDL,
independently of potential confounding factors. The
mechanism by which the clock molecule and the varia-
tion in its gene could be associated with sdLDL remain
to be elucidated. The Clock mutant mouse has altered
feeding patterns accompanied by the development of
obesity and elevated TG, glucose and leptin levels [11],
and mutations in Clock and Bmal influence the diurnal
variation in TG and glucose concentrations [31]. The
Clock mutant mice is also both hyperphageic and obese,
and exhibits abnormalities in circulating levels of glu-
cose, lipids, and hormones/adipokines, consistent with a
cardiometabolic syndrome phenotype [32]. It was
reported, however, that the 3111 T/C SNP does not
alter the amino acid sequence of the clock protein
because 3111 T/C SNP locates in the 3’-flanking region
of the Clock gene. Therefore, we speculate that the 3111
T/C SNP may affect Clock mRNA level, helping to alter
clock protein levels and thereby disturbing other clock
molecules’ network and circadian rhythmicity. The 3111
T/C SNP has been associated with sleep disruptuin in
humans in many studies [13,16,33-38] but not all [39].
Further examination is needed to clarify the mechanism
underlying the association between the 3111 T/C SNP
and sdLDL.
There are several limitations to our study. First, no
assessment of sleep patterns (sleep onset time, wake
time, and daytime sleepiness) was performed, although
there was no significant difference in the prevalence of
skipping breakfast and sleeping time. Second, only one
SNP was examined. It has been reported that the haplo-
types of rs1554483G and rs4864548A are associated
with a 1.8-fold increase in the risk of overweightness or
obesity [40]. So, we would need to consider more stu-
dies on the association between 3111 T/C tag and other
variants. Third, considering the small sample size in our
study, we need to investigate the replication in
independent cohorts to confirm our observed associa-
tion. In the light of our findings, it will be important to
further establish the effects of the 3111T/C SNP on
gene regulation.
Conclusion
In conclusion, our findings indicate the 3111T/C SNP of
the Clock gene might modify the existence of sdLDL in
the circulation. Understanding the mechanisms under-
pinning the relationship between the environment, our
circadian rhythms, and dyslipidemia in the development
of cardiovascular disease will provide important path-
ways for both prevention and management of these
conditions.
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